Report      Database

    China Molecular Diagnostics Market, Test Volume & Forecast by Oncology Test (Breast Cancer, Colorectal Cancer, Prostate Cancer) Infectious Disease Test (Virology, HPV), Genetic Test (Blood Screening, HLA) - 2nd Edition

    Date: 28 Aug, 2017              Type: Diagnostics              Pages: 105

    China Molecular Diagnostics Market, Test Volume & Forecast by Oncology Test (Breast Cancer, Colorectal Cancer, Prostate Cancer) Infectious Disease Test (Virology, HPV), Genetic Test (Blood Screening, HLA) - 2nd Edition
    • Electronic Access - Single User License
      $1,200.00
    • CD-ROM Mail Delivery
      $1,300.00
    • Hard-copy Mail Delivery
      $1,300.00
    • Electronic Access - Multi User License
      $1,800.00

    Get Free 10% Customization in this Report

    China molecular diagnostics market is growing at a fast pace owing to rising prevalence of infectious diseases and cancer cases in the region coupled with growing geriatric population. It is projected that China molecular diagnostics market will exceed US$ 1.5 Billion by the end of 2022. Molecular diagnostics are extremely effective in diagnosing and preventing diseases, offering accurate and precise healthcare interventions in the early stages of diseases.


    China Molecular Diagnostics Segments Market

    China molecular diagnostics market has been segmented into three major categories: Oncology Testing, Infectious Disease Testing and Genetic Disease Testing. Further, Oncology Testing has been segmented into three major categories: Breast Cancer Testing, Colorectal Cancer Testing and Prostate Cancer Testing. Infectious Disease Testing has been segmented into two major categories, namely, virology and HPV and Genetic Testing has been segmented into Blood Screening and HLA.

    China Infectious Disease test market; Virology tests accounts for the highest market share. Furthermore, our analysis found that nearly 300 million molecular diagnostic tests will be performed in China by the end of 2022 of which Virology accounts for one of the most performed tests segments.

    Increasing incidence of contagious diseases along with cancer cases and the rise of the private healthcare sector in China, with the development of socio-economic conditions and the growth of a wealthy middle class, has increased the quest for affordable and quality healthcare across the region are some of the contributors which are anticipated to drive the molecular diagnostics market over the forecast period.


    This is the 5th report on Molecular Diagnostics industry published by Renub Research. This report titled “China Molecular Diagnostics Market, Test Volume & Forecast by Oncology Test (Breast Cancer, Colorectal Cancer, Prostate Cancer) Infectious Disease Test (Virology, HPV), Genetic Test (Blood Screening, HLA)” provides a comprehensive assessment of the fast–evolving, high–growth China Molecular diagnostics market. This 105 page report with 55 Figures and 14 Tables studies the China Molecular Diagnostic market from 4 view points: 

    1.    Market & Forecast 
    2.    Molecular Diagnostics Segments Market & Forecast
    3.    Molecular Diagnostics Segments Test Volume & Forecast 
    4.    Profiles of Select Private Clinical Labs & Diagnostic Services Companies 

     

    Segments Covered in this report are as follows:

    Oncology Test Market and Volume

    •    Breast Cancer
    •    Colorectal Cancer
    •    Prostate Cancer

     

    Infectious Disease Test Market and Volume

    •    Virology
    •    HPV

     

    Genetic Test Market and Volume

    •    Blood Screening 
    •    HLA


    Key Players Analysis

    •    Zhejiang Di’an Diagnostics Technology Co., Ltd.
    •    ADICON Clinical Laboratories (Privately held)
    •    Guangzhou Kingmed Diagnostics Center Co. Ltd.
    •    Kindstar Global (Privately held)
    •    BGI–Shenzhen
    •    OriGene Technologies    

     

    Key questions answered in the study

    •    What is China molecular diagnostics market size from 2011 to 2022?
    •    What is China molecular diagnostics tests volume from 2011 to 2022?
    •    What are China molecular diagnostics segments market & Forecast? 
    •    What are the growth drivers of Molecular diagnostics in China?


     

     

    Content from Old Report is given below:

    The user can buy this report in Chapters from Purchase by Chapter section given above

     

    China Molecular Diagnostics Market Overview
     
    China Molecular Diagnostics is a Billion dollar industry and its growing year on year rapidly. Molecular diagnostics holds immense potential in future of China Diagnostics Sector. It is predicted that China will perform over 300 Million molecular diagnostic tests during the forecasting period 2015 – 2019. Infectious disease and Oncology Testing both have almost equal share in China Molecular Diagnostics Sector. However in further sub–segmenting of molecular diagnostics market share perspective Virology Cancer Test holds the highest market share followed by Colorectal cancer and Breast Cancer Test.     

    Rising demand from middle class for high quality healthcare products, rapid development in the diagnosis of infectious diseases and increasing number of private hospitals are some of the growth drivers which is fueling this sector. However industry faces some kind of challenges such as shortage of lab technicians, lack of expertise in advanced technology in the local companies etc.

    This is the 4th report on Molecular Diagnostics industry published by Renub Research. This report titled “China Molecular Diagnostics Market, Test Volume & Forecast” provides a comprehensive assessment of the fast–evolving, high–growth China Molecular diagnostics market. This 84 page report with 55 Figures and 13 Tables studies the China Molecular Diagnostic market from 4 view points:

    1)  Market & Forecast
    2)  Application Wise Market & Forecast
    3)  Application Wise Test Volume & Forecast
    4)  Profiles of Select Private Clinical Labs & Diagnostic Services Companies

    Data Sources

    This report is built using data and information sourced from proprietary databases, primary and secondary research and in–house analysis by Renub Research team of industry experts.

    Primary sources include industry surveys and telephonic interviews with industry experts.

    Secondary sources information and data has been collected from various printable and non–printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.

    1.    Research Findings

    2.    China Molecular Diagnostic Market & Test Volume Forecast
    2.1    China Molecular Diagnostic Market

    2.2    China Molecular Diagnostic Test Volume

    3.    China Molecular Diagnostic Market Share Analysis
    3.1    Market Share – (Oncology, Infectious, Genetic) Testing

    3.2    Market Share – Segments (Breast, Colorectal, Prostate, Virology, HPV, Blood Screening, HLA) Cancer Tests

    4.    China Molecular Diagnostic Volume Share (2011 – 2022)
    4.1    Volume Share – (Oncology, Infectious, Genetic) Testing

    4.2    Volume Share – Segments (Breast, Colorectal, Prostate, Virology, HPV, Blood Screening, HLA) Cancer Tests

    5.    Segments Test Volume – China Molecular Diagnostics
    5.1    Volume Share – (Breast, Colorectal, Prostate) Oncology Test

    5.2    Oncology Test Volume
    5.2.1    Breast Cancer Test Volume
    5.2.2    Colorectal Cancer Test Volume
    5.2.3    Prostate Cancer Test Volume

    5.3    Volume Share – (Virology, HPV) Infectious Disease Test

    5.4    Infectious Disease Test Volume
    5.4.1    Virology Test Volume
    5.4.2    HPV Test Volume

    5.5    Volume Share – (Blood Screening, HLA) Genetic Test

    5.6    Genetic Test Volume
    5.6.1    Blood Screening Test Volume
    5.6.2    HLA Test Volume

    6.    Segments Test Market – China Molecular Diagnostics Market (2011 – 2022)
    6.1    Market Share – (Breast, Colorectal, Prostate) Oncology Test

    6.2    Oncology Test Market
    6.2.1    Breast Cancer Test Market
    6.2.2    Colorectal Cancer Test Market
    6.2.3    Prostate Cancer Test Market

    6.3    Market Share – (Virology, HPV) Infectious Disease Test

    6.4    Infectious Disease Test Market
    6.4.1    Virology Test Market
    6.4.2    HPV Test Market

    6.5    Market Share – (Blood Screening, HLA) Genetic Test

    6.6    Genetic Test Market
    6.6.1    Blood Screening Market
    6.6.2    HLA Test Market

    7.    China Healthcare Insurance Schemes
    7.1    China Healthcare Insurance Schemes
    7.1.1    NRCMS
    7.1.2    UEBMI
    7.1.3    URBMI
    7.1.4    Private Health Insurance
    7.1.5    Cost-sharing and out-of-pocket Spending

    8.    Growth Drivers
    8.1    Rising Order for High Quality Healthcare Products

    8.2    Growing Cases of Lifestyle Diseases

    8.3    Rapid Diagnosis of Infectious Diseases

    8.4    Rise in Number of Private Hospitals & Independent Diagnostics Clinics
    8.4.1    Rise in the Number of Hospital Beds across all Medical Institutions

    8.5    Increasing Automation

    9.    Challenges
    9.1    Nil Government Support & Public Awareness

    9.2    Dearth of Trained Medical Technicians

    9.3    Reimbursement Rates differ from Province to Province in China
    9.3.1    Chinese Government Regulating Laboratory Testing in China

    10.    Profiles of Select Private Clinical Labs and Diagnostic Services Companies
    10.1    Zhejiang Di’an Diagnostics Technology Co., Ltd.
    10.1.1    Company Overview
    10.1.2    Products and Services Offered by Di’an

    10.2    ADICON Clinical Laboratories (Privately held)
    10.2.1    Company Overview
    10.2.2    Products and Services Offered by ADICON

    10.3    Guangzhou Kingmed Diagnostics Center Co. Ltd.
    10.3.1    Company Overview
    10.3.2    Products and Services Offered by Kingmed

    10.4    Kindstar Global (Privately held)
    10.4.1    Company Overview
    10.4.2    Products and Services Offered by Kindstar

    10.5    BGI–Shenzhen
    10.5.1    Company Overview
    10.5.2    BGI’s Innovative Approach

    10.6    OriGene Technologies
    10.6.1    Company Overview
    10.6.2    Products and Services Offered by OriGene

     

    List of Figures

    Figure 2–1: China – Molecular Diagnostic Market (Million US$), 2011 – 2016
    Figure 2–2: China – Forecast for Molecular Diagnostic Market (Million US$), 2017 – 2022
    Figure 2–3: China – Molecular Diagnostic Test Volume (Million), 2011 – 2016
    Figure 2–4: China – Forecast for Molecular Diagnostic Test Volume (Million), 2017 – 2022

    Figure 3–1: China – Molecular Diagnostic Market Share (Percent), 2011 – 2016
    Figure 3–2: China – Forecast for Molecular Diagnostic Market Share (Percent), 2017 – 2022
    Figure 3–5: China – Molecular Diagnostic Test Volume Share (Percent), 2011 – 2016
    Figure 3–6: China – Forecast for Molecular Diagnostic Test Volume Share (Percent), 2017 – 2022

    Figure 4–1: China – Molecular Oncology Test Volume Share (Percent), 2011 – 2016
    Figure 4–2: China – Forecast for Molecular Oncology Test Volume Share (Percent), 2017 – 2022
    Figure 4–3: Rural China – Cancer Screening Sites by Cancer Type (Number), 2013
    Figure 4–4: China – Oncology Test Volume (Million), 2011 – 2016
    Figure 4–5: China – Forecast for Oncology Test Volume (Million), 2017 – 2022
    Figure 4–6: China –Breast Cancer Molecular Test Volume (Million), 2011 – 2016
    Figure 4–7: China – Forecast for Breast Cancer Molecular Test Volume (Million), 2017 – 2022
    Figure 4–8: China –Colorectal Cancer Test Volume (Million), 2011 – 2016
    Figure 4–9: China – Forecast for Colorectal Cancer Test Volume (Million), 2017 – 2022
    Figure 4–10: China –Prostate Cancer Test Volume (Million), 2011 – 2016
    Figure 4–11: China – Forecast for Prostate Cancer Test Volume (Million), 2017 – 2022
    Figure 4–14: China –Infectious Disease Test Volume (Million), 2011 – 2016
    Figure 4–15: China – Forecast for Infectious Disease Test Volume (Million), 2017 – 2022
    Figure 4–16: China –Virology Test Volume (Million), 2011 – 2016
    Figure 4–17: China – Forecast for Virology Test Volume (Million), 2017 – 2022
    Figure 4–18: China –HPV Test Volume (Thousand), 2011 – 2016
    Figure 4–19: China – Forecast for HPV Test Volume (Thousand), 2017 – 2022
    Figure 4–22: China –Genetic Test Volume (Million), 2011 – 2016
    Figure 4–23: China – Forecast for Genetic Test Volume (Million), 2017 – 2022
    Figure 4–24: China –Blood Screening Test Volume (Million), 2011 – 2016
    Figure 4–25: China – Forecast for Blood Screening Test Volume (Million), 2017 – 2022
    Figure 4–26: China – HLA Test Volume (Thousand), 2011 – 2016
    Figure 4–27: China – Forecast for HLA Test Volume (Thousand), 2017 – 2022

    Figure 5–1: China – Molecular Oncology Test Market Share (Percent), 2011 – 2016
    Figure 5–2: China – Forecast for Molecular Oncology Test Market Share (Percent), 2017 – 2022
    Figure 5–3: China –Oncology Test Market (Million US$), 2011 – 2016
    Figure 5–4: China – Forecast for Oncology Test Market (Million US$), 2017 – 2022
    Figure 5–5: China –Breast Cancer Test Market (Million US$), 2011 – 2016
    Figure 5–6: China – Forecast for Breast Cancer Test Market (Million US$), 2017 – 2022
    Figure 5–7: China –Colorectal Cancer Test Market (Million US$), 2011 – 2016
    Figure 5–8: China – Forecast for Colorectal Cancer Test Market (Million US$), 2017 – 2022
    Figure 5–9: China –Prostate Cancer Testing Market (Million US$), 2011 – 2016
    Figure 5–10: China – Forecast for Prostate Cancer Testing Market (Million US$), 2017 – 2022
    Figure 5–13: China –Infectious Disease Test Market (Million US$), 2011 – 2016
    Figure 5–14: China – Forecast for Infectious Disease Test Market (Million US$), 2017 – 2022
    Figure 5–15: China –Virology Test Market (Million US$), 2011 – 2016
    Figure 5–16: China – Forecast for Virology Test Market (Million US$), 2017 – 2022
    Figure 5–17: China –HPV Test Market (Million US$), 2011 – 2016
    Figure 5–18: China – Forecast for HPV Test Market (Million US$), 2017 – 2022
    Figure 5–21: China –Genetic Testing Market (Million US$), 2011 – 2016
    Figure 5–22: China – Forecast for Genetic Testing Market (Million US$), 2017 – 2022
    Figure 5–23: China –Blood Screening Market (Million US$), 2011 – 2016
    Figure 5–24: China – Forecast for Blood Screening Market (Million US$), 2017 – 2022
    Figure 5–25: China – HLA Test Market (Thousand US$), 2011 – 2016
    Figure 5–26: China – Forecast for HLA Test Market (Thousand US$), 2017 – 2022

    Figure 6–1: China – Healthcare Spending (Billion US$), 2011 &2020

    Figure 8–1: Kindstar – Collaboration with Hospitals in China (Number), 2006–2012
     

     

    List of Tables    
        
    Table 3–1: China – Molecular Diagnostic Application Market Share (Percent), 2011 – 2016    
    Table 3–2: China – Forecast for Molecular Diagnostic Application Market Share (Percent), 2017 – 2022    
    Table 3–3: China – Molecular Diagnostic Test Volume Application Share (Percent), 2011 – 2016    
    Table 3–4: China – Forecast for Molecular Diagnostic Test Volume Application Share (Percent), 2017 – 2022    

    Table 4–1: China – Molecular Infectious Disease Test Volume Share (Percent), 2011 – 2016    
    Table 4–2: China – Forecast for Molecular Infectious Disease Test Volume Share (Percent), 2017 – 2022    
    Table 4–3: China – Molecular Genetic Test Volume Share (Percent), 2011 – 2016    
    Table 4–4: China – Forecast for Molecular Genetic Test Volume Share (Percent), 2017 – 2022    

    Table 5–1: China – Molecular Infectious Disease Test Market Share (Percent), 2011 – 2016    
    Table 5–2: China – Forecast for Molecular Infectious Disease Test Market Share (Percent), 2017 – 2022    
    Table 5–3: China – Molecular Genetic Test Market Share (Percent), 2011 – 2016    
    Table 5–4: China – Forecast for Molecular Genetic Test Market Share (Percent), 2017 – 2022    

    Table 6–1: China – Major Diagnostic Reagent R&D and Manufacturing Companies in Infectious Diseases, 2010    

    Table 8‑1: Number of Hospital Beds for every 1,000 people    
     

    • Description
      Price
    • Chapter 1 & 2     Pages : 5
      $200
    • Chapter 3     Pages : 7
      $390
    • Chapter 4     Pages : 20
      $390
    • Chapter 5     Pages : 19
      $390
    • Chapter 6     Pages : 4
      $150
    • Chapter 7     Pages : 2
      $90
    • Chapter 8     Pages : 13
      $200

    Related Products